Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 100 Fast-growings companies in Monoclonal antibody
by Most Patent Filing In 5 Years in the China in 2021

The Monoclonal antibody top 100 is Discovery PatSnap’ annual ranking of the top 100 Most Patent Filing In 5 Years Monoclonal antibody Fast-growings in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
#
Company Name
Region
Tech Topics
Total
1
Patent: 159
2
Patent: 69
3
Patent: 61
4
Patent: 54
5
Patent: 51
6
Patent: 46
7
Pinyin,Educational institution,Cancer immunotherapy,
...[+2]
Patent: 45
8
Patent: 42
9
Patent: 41
10
Patent: 40
11
Patent: 39
12
Health care,Antibody,Medical laboratory,
...[+2]
Patent: 38
13
Patent: 37
14
Medicine,Recombinant Human Growth Hormones,Growth hormone,
...[+2]
Patent: 36
15
Patent: 33
16
Patent: 32
17
Patent: 32
18
Patent: 31
19
Patent: 30
20
Agronomy,Basic science,Agricultural science,
...[+2]
Patent: 30
21
Patent: 30
22
Patent: 27
23
Patent: 25
24
Patent: 25
25
Biotechnology,Orphan drug,Cardiovascular agent,
...[+2]
Patent: 24
26
Medicine,Health care,Biosimilar,
...[+2]
Patent: 23
27
Patent: 23
28
Patent: 23
29
Patent: 23
30
Patent: 22
31
Academic Training,Educational institution,Graduate degree,
...[+2]
Patent: 21
32
Patent: 21
33
Patent: 21
34
Medicine,Health care,Immunoassay,
...[+2]
Patent: 21
35
Pinyin,Social science,Educational institution,
...[+2]
Patent: 20
36
Pinyin,Mainland China,Social science,
...[+2]
Patent: 20
37
Patent: 20
38
Patent: 19
39
Pinyin,Coronavirus,Jurisdiction,
...[+2]
Patent: 18
40
Patent: 18
41
National security,BCG vaccine,HIV vaccine,
...[+2]
Patent: 18
42
CONTEST,Biological membrane,Biofabrication,
...[+2]
Patent: 18
43
Academic Training,Educational institution,Graduate degree,
...[+2]
Patent: 18
44
Western culture,TUTOR,Silicon carbide,
...[+2]
Patent: 16
45
Patent: 16
46
Patent: 16
47
Patent: 16
48
Patent: 16
49
Patent: 14
50
Patent: 14
51
Patent: 14
52
Patent: 14
53
Pinyin,Public university,Medicine,
...[+2]
Patent: 14
54
Patent: 14
55
Patent: 13
56
Patent: 13
57
Patent: 13
58
Biopharmaceutical,Drug,Health care,
...[+2]
Patent: 12
59
Patent: 12
60
Patent: 12
61
Nanjing Leads Biolabs Co. Ltd.
Patent: 12
62
Patent: 12
63
Patent: 12
64
Invasive fungal disease
Patent: 11
65
Patent: 11
66
Patent: 11
67
Fishery,Pinyin,Social science,
...[+2]
Patent: 11
68
Patent: 11
69
Medicine,Diagnostic microbiology,Immunochemistry,
...[+2]
Patent: 11
70
Publishing
Patent: 11
71
Patent: 11
72
Patent: 11
73
Patent: 11
74
Patent: 10
75
Patent: 10
76
Management science,Square kilometer,Social science,
...[+2]
Patent: 10
77
Patent: 10
78
Patent: 10
79
Patent: 10
80
Medical school,Engineering education,Internationalization,
...[+2]
Patent: 10
81
Education development,Cell therapy,Drug repositioning,
...[+2]
Patent: 9
82
Patent: 9
83
Patent: 9
84
Patent: 9
85
Health care,Immunotherapy,Drug
Patent: 9
86
Patent: 9
87
Supervisor,Vocational education,Chemistry,
...[+2]
Patent: 9
88
Medicine,Health care,Diagnostic Reagent,
...[+2]
Patent: 9
89
Patent: 9
90
Patent: 8
91
Patent: 8
92
Pinyin,Literature,Computer science,
...[+2]
Patent: 8
93
Patent: 8
94
Patent: 8
95
Jiangsu Huaiyu Pharmaceutical Co Ltd
Patent: 8
96
Patent: 8
97
Patent: 8
98
Patent: 8
99
Patent: 8
100
Patent: 8
Page generation time: Jul 20 2025